Skip to main content
Log in

Influence of Drugs on Sleep Apnoea in Stroke Patients

  • Clinical Pharmacovigilance
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Objective: It is known that a number of different drugs influence respiration. We hypothesised that certain drugs affect central or obstructive sleep apnoea in patients who have experienced a stroke. The aim of this study was to analyse the possible influence of drugs in this group of patients.

Design and Setting: Cross-sectional study in a stroke rehabilitation unit.

Study Participants: 132 patients (78 women and 54 men) consecutively admitted to a stroke rehabilitation unit, with a mean age of 77 ± 8 years.

Main Outcome Measures: All patients underwent a brain computer tomography scan in the acute phase after the stroke. Overnight respiratory sleep recordings were performed on all patients 23 ± 7 days after experiencing a stroke. Medications were analysed at the time of the overnight respiratory sleep recordings. The number of central and obstructive apnoea-hypopnoea indices per hour of sleep was measured.

Results: Both short- and long-acting calcium antagonists demonstrated a strong association with central apnoeas [short-acting B-value = 15.21, 95% confidence interval (CI) 5.6 to 24.8, p < 0.002; long-acting B-value = 10.05, 95% CI 3.7 to 16.4, p < 0.002]. This association was independent of hypertension, angina pectoris and cardiac arrhythmias. Oral estriol (estrogen) was negatively associated with central sleep apnoeas (B-value = −9.19, 95 % CI −15.4 to −3.0, p < 0.004). Antiepileptic drugs had the strongest association with obstructive apnoeas (B-value = 10.37, 95% CI 2.0 to 18.7, p < 0.016).

Conclusions: Both short- and long-acting calcium antagonists were associated with central apnoeas-hypopnoeas, and antiepileptic drugs with obstructive apnoeas-hypopnoeas in stroke patients. However, the clinical significance of these findings is unclear and future studies are needed to elucidate a possible cause and effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II
Table III
Table IV

Similar content being viewed by others

References

  1. Dyken ME, Somers VK, Yamada T, et al. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27(3): 401–7

    Article  PubMed  CAS  Google Scholar 

  2. Good DC, Henkle JQ, Gelber D, et al. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27(2): 252–9

    Article  PubMed  CAS  Google Scholar 

  3. Bassetti C, Aldrich M. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999; 22(2): 217–23

    PubMed  CAS  Google Scholar 

  4. Palomäki H. Snoring and the risk of ischemic brain infarction. Stroke 1991; 22(8): 1021–5

    Article  PubMed  Google Scholar 

  5. Partinen M. Ischaemic stroke, snoring and obstructive sleep apnoea. J Sleep Res 1995; 4 Suppl. 1: 156–9

    Article  PubMed  Google Scholar 

  6. Bassetti C, Aldrich MS, Chervin RD, et al. Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients Neurology 1996; 47(5): 1167–73

    Article  PubMed  CAS  Google Scholar 

  7. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea Eur Respir J 1995; 8(7): 1161–78

    Article  PubMed  CAS  Google Scholar 

  8. Bålfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas. Am J Respir Crit Care Med 1994; 150 (6 Pt 1): 1587–91

    PubMed  Google Scholar 

  9. Franklin KA, Nilsson JB, Sahlin C, et al. Sleep apnoea and nocturnal angina. Lancet 1995; 345(8957): 1085–7

    Article  PubMed  CAS  Google Scholar 

  10. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med 1996; 101(3): 251–6

    Article  PubMed  CAS  Google Scholar 

  11. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109(3): 659–63

    Article  PubMed  CAS  Google Scholar 

  12. Naughton MT, Bradley TD. Sleep apnea in congestive heart failure. Clin Chest Med 1998; 19(1): 99–113

    Article  PubMed  CAS  Google Scholar 

  13. Cheyne J. A case of apoplexy, in which the fleshy part of the heart was converted into fat. Dublin Hospital Reports and Communications in Medicine and Surgery 1818; 2: 216–23

    Google Scholar 

  14. Franklin KA, Eriksson P, Sahlin C, et al. Reversal of central sleep apnea with oxygen. Chest 1997; 111(1): 163–9

    Article  PubMed  CAS  Google Scholar 

  15. Nachtmann A, Siebler M, Rose G, et al. Cheyne-Stokes respiration in ischemic stroke. Neurology 1995; 45(4): 820–1

    Article  PubMed  CAS  Google Scholar 

  16. Hanly PJ, Millar TW, Steljes DG, et al. Respiration and abnormal sleep in patients with congestive heart failure. Chest 1989; 96(3): 480–8

    Article  PubMed  CAS  Google Scholar 

  17. Javaheri S, Parker TJ, Wexler L, et al. Occult sleep-disordered breathing in stable congestive heart failure [published erratum appears in Ann Intern Med 1995; 123(1): 77]. Ann Intern Med 1995; 122(7): 487–92

    PubMed  CAS  Google Scholar 

  18. Pryor WW. Cheyne-Stokes respiration in patients with cardiac enlargement and prolonged circulation time. Circulation 1951; 4: 233–8

    Article  PubMed  CAS  Google Scholar 

  19. Khoo MC, Kronauer RE, Strohl KP, et al. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 1982; 53(3): 644–59

    PubMed  CAS  Google Scholar 

  20. Naughton M, Benard D, Tarn A, et al. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 1993; 148(2): 330–8

    PubMed  CAS  Google Scholar 

  21. Franklin KA, Sandström E, Johansson G, et al. Hemodynamics, cerebral circulation, and oxygen saturation in Cheyne-Stokes respiration. J Appl Physiol 1997; 83(4): 1184–91

    PubMed  CAS  Google Scholar 

  22. Mendelson WB, Garnett D, Gillin JC. Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Nerv Ment Dis 1981; 169(4): 261–4

    Article  PubMed  CAS  Google Scholar 

  23. Guilleminault C, Silvestri R, Mondini S, et al. Aging and sleep apnea: action of benzodiazepine, acetazolamide, alcohol, and sleep deprivation in a healthy elderly group. J Gerontol 1984; 39(6): 655–61

    Article  PubMed  CAS  Google Scholar 

  24. Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996; 335(8): 562–7

    Article  PubMed  CAS  Google Scholar 

  25. White DP, Zwillich CW, Pickett CK, et al. Central sleep apnea Improvement with acetazolamide therapy. Arch Intern Med 1982; 142(10): 1816–9

    Article  PubMed  CAS  Google Scholar 

  26. DeBacker WA, Verbraecken J, Willemen M, et al. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995; 151(1): 87–91

    PubMed  CAS  Google Scholar 

  27. Rubin AH, Alroy GG, Peled R, et al. Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome. Eur Neurol 1986; 25(2): 81–5

    Article  PubMed  CAS  Google Scholar 

  28. Block AJ, Wynne JW, Boysen PG, et al. Menopause, medroxy-progesterone and breathing during sleep. Am J Med 1981; 70(3): 506–10

    Article  PubMed  CAS  Google Scholar 

  29. Pickett CK, Regensteiner JG, Woodard WD, et al. Progestin and estrogen reduce sleep-disordered breathing in postmeno-pausal women. J Appl Physiol 1989; 66(4): 1656–61

    PubMed  CAS  Google Scholar 

  30. Franklin K, Lundgren R, Rabben T. Sleep apnoea syndrome treated with oestradiol and cyclic medroxyprogesterone. Lancet 1991; 338(8761): 251–2

    Article  PubMed  CAS  Google Scholar 

  31. Brownell LG, West P, Sweatman P, et al. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med 1982; 307(17): 1037–42

    Article  PubMed  CAS  Google Scholar 

  32. Whyte KF, Gould GA, Airlie MA, et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988; 11(5): 463–72

    PubMed  CAS  Google Scholar 

  33. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991; 100(2): 416–21

    Article  PubMed  CAS  Google Scholar 

  34. Kraiczi H, Hedner J, Dahlöf P, et al. Effect of serotonin uptake on breathing during sleep and daytime symptoms in obstructive sleep apnea Sleep 1999; 22(1): 61–7

    PubMed  CAS  Google Scholar 

  35. Carley DW, Trbovic SM, Radulovacki M. Hydralazine reduces elevated sleep apnea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats. Sleep 1996; 19(5): 363–6

    PubMed  CAS  Google Scholar 

  36. Weichler U, Herres Mayer B, Mayer J, et al. Influence of anti-hypertensive drug therapy on sleep pattern and sleep apnea activity Cardiology 1991; 78(2): 124–30

    CAS  Google Scholar 

  37. Gustafson Y, Olsson T, Eriksson S, et al. Acute confusional states in stroke patients. Cerebrovasc Dis 1991; 1: 257–64

    Article  Google Scholar 

  38. Report of the WHO Task Force on stroke and other cerebro-vascular disorders. Recommendations on stroke prevention, diagnosis and therapy Stroke 1989; 20: 1407-31

    Google Scholar 

  39. Alderman MH, Cohen H, Roqué R, et al. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997; 349: 594–8

    Article  PubMed  CAS  Google Scholar 

  40. Svanborg E, Larsson H, Carlsson Nordlander B, et al. A limited diagnostic investigation for obstructive sleep apnea syndrome. Oximetry and static charge sensitive bed. Chest 1990; 98(6): 1341–5

    Article  PubMed  CAS  Google Scholar 

  41. American Sleep Disorders Association. Intrinsic sleep disorders. In: Thorpy MJ, editor. The international classification of sleep disorders diagnostic and coding manual. Lawrence, Kansas: Allan Press, 1990: 52–61

    Google Scholar 

  42. SPSS advanced statistics 6.1. [Computer program] United States of America. 1994

  43. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274(8): 620–5

    Article  PubMed  CAS  Google Scholar 

  44. Pahor M, Guralnik JM, Corti MC, et al. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995; 43(11): 1191–7

    PubMed  CAS  Google Scholar 

  45. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92(5): 1326–31

    Article  PubMed  CAS  Google Scholar 

  46. Furberg CD, Psaty BM. Calcium antagonists: antagonists or protagonists of mortality in elderly hypertensives? J Am Geriatr Soc 1995; 43(11): 1309–10

    PubMed  CAS  Google Scholar 

  47. Packer M. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure Circulation 1989; 80(6 Suppl.): IV59–67

    CAS  Google Scholar 

  48. Elkayam U, Amin J, Mehra A, et al. Aprospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990; 82(6): 1954–61

    Article  PubMed  CAS  Google Scholar 

  49. Calcium antagonist caution [editorial]. Lancet 1991; 337: 885-6

  50. McEwen BS, Alves SE. Estrogen actions in the central nervous system Endocr Rev 1999; 20(3): 279–307

    CAS  Google Scholar 

  51. Cistulli PA, Barnes DJ, Grunstein RR, et al. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994; 49(7): 699–702

    Article  PubMed  CAS  Google Scholar 

  52. Burn J, Dennis M, Bamford J, et al. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 1997; 315(7122): 1582–7

    Article  PubMed  CAS  Google Scholar 

  53. Devinsky O, Ehrenberg B, Barthlen GM, et al. Epilepsy and sleep apnea syndrome. Neurology 1994; 44(11): 2060–4

    Article  PubMed  CAS  Google Scholar 

  54. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996; 27(9): 1641–6; discussion 1647

    Article  PubMed  CAS  Google Scholar 

  55. Zucconi M, Ferini Strambi L, Castronovo V, et al. An unattended device for sleep-related breathing disorders: validation study in suspected obstructive sleep apnoea syndrome. Eur Respir J 1996; 9(6): 1251–6

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The study was supported by grants from the Gun and Bertil Stohnes Foundation, the Borgerskapets in Umeå Foundation, 1987 year’s Foundation for Stroke Research, the Fund for Medical Research at Umeå University Hospital, the Foundation for ‘Gamla Tjänarinnor’, the Thureús Fund and the Fund of Loo and Hans Osterman. The authors’ thank Ulla Britt Johansson RN and Ann-Christine Löfgren RN for data collection, Carin Sahlin-Ingridsson RTA for scoring the sleep apnoea recordings and Associate Professor Dr Sture Eriksson for statistical advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olov Sandberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sandberg, O., Franklin, K.A., Bucht, G. et al. Influence of Drugs on Sleep Apnoea in Stroke Patients. Clin. Drug Investig. 19, 447–455 (2000). https://doi.org/10.2165/00044011-200019060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200019060-00007

Keywords

Navigation